Related Experiment Video

Updated: May 17, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Bile acid handling in cystic fibrosis: marked phenotypic differences between mouse models

Marcel J C Bijvelds, Hugo R de Jonge, Henkjan J Verkade

    Gastroenterology
    |October 23, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
    06:26

    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

    Published on: July 18, 2025

    Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
    04:38

    Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

    Published on: March 28, 2018

    Related Experiment Videos

    Last Updated: May 17, 2026

    A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
    09:12

    A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

    Published on: February 3, 2023

    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
    06:26

    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

    Published on: July 18, 2025

    Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
    04:38

    Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

    Published on: March 28, 2018

    Related Concept Videos

    Cystic Fibrosis: Pathogenesis01:23

    Cystic Fibrosis: Pathogenesis

    Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
    CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
    Cystic Fibrosis: Management01:24

    Cystic Fibrosis: Management

    Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
    Sinus disease and chronic sinusitis...

    Articles linked to this work by shared authors, journal, and citation graph.

    Maternal influences on infant gut microbiome and health.

    Nature·2026

    Liver-directed gene therapy results in amelioration of progressive familial intrahepatic cholestasis type 2 in mice.

    Hepatology communications·2026

    N-acetylcysteine for non-paracetamol-induced acute liver failure in children: A systematic review and meta-analysis.

    British journal of clinical pharmacology·2026

    Mice with humanized FXR ligand-binding domain display distinct metabolic responses upon pharmacological FXR stimulation.

    Journal of lipid research·2026

    Physiological and Anatomical Alterations in Children with Liver Cirrhosis.

    Pharmaceutical research·2026

    A Molecular Mechanism of Intrahepatic Cholestasis in Osteo-Oto-Hepato-Enteric Syndrome.

    Cellular and molecular gastroenterology and hepatology·2026

    Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort.

    Gastroenterology·2026

    Artificial Intelligence-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically Enhanced Deep Learning.

    Gastroenterology·2026

    Serotonergic Signaling in Gastric Physiology and Motility Disorders.

    Gastroenterology·2026

    [Omnipresent Lactate: Normalization of the Tumor Microenvironment as a Prerequisite for Any Anticancer Therapy].

    Molekuliarnaia biologiia·2026

    Liver cirrhosis is associated with altered glucocorticoid metabolism related to disease severity.

    Journal of internal medicine·2026

    Clinical Significance and Subtype Distribution of Blastocystis Infection with Colonoscopy Findings.

    Iranian journal of parasitology·2026

    Liver-kidney crosstalk in primary biliary cholangitis: insights into the mechanisms of renal involvement.

    Frontiers in immunology·2026

    Key challenges for in vitro testing of oral tobacco and nicotine products for regulatory applications: Recommendations for using in vitro toxicity and disease models.

    Alternatives to laboratory animals : ATLA·2026

    Lipid-Rich Urothelial Carcinoma: A Contemporary Clinicopathologic Study of 40 Patients With Transcriptional Tumor Profiling.

    The American journal of surgical pathology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us